MedPath

iShanCare

Approved
Approval ID

361b41f7-4dbb-3f35-e063-6294a90a7e9f

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 27, 2025

Manufacturers
FDA

Shenzhen Ishan Technology Co., Ltd

DUNS: 554484192

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mint extract

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code73076-180
Product Classification
G
Generic Name
Mint extract
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 27, 2025
FDA Product Classification

INGREDIENTS (10)

CARBOMER 940Inactive
Code: 4Q93RCW27E
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DIATOMACEOUS EARTHInactive
Code: 2RF6EJ0M85
Classification: IACT
MINTActive
Quantity: 0.5 g in 100 g
Code: FV98Z8GITP
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 1/1/2025

Lable

cooling patch

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/1/2025

Directions

Clean and dry the skin

Pick out patch

Peel off film

Stick to skin

Note: lf desired, cut gel sheet to suitable sizewith scissors.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 1/1/2025

Active ingredient

Mint Extract 0.5%

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 1/1/2025

Inactive ingredient

Water, Carbomer, Crospovidone,Edetate Disodium Anhydrous, Povidone.FD&C Blue No.1,CarboxymethylcelluloseSodium,Sodium Benzoate, Diatomaceous Earth.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 1/1/2025

Keep out of reach of children.

if swallowed, call poison control or seek medical help.

OTC - ASK DOCTOR/PHARMACIST SECTION

LOINC: 50568-5Updated: 1/1/2025

Ask a doctor if

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 1/1/2025

Stop use and ask a doctor if

pain worsens or persists, or if youexperience any of these symptoms: burning, itching, rash, or other changes in theskin where the product was placed.

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 1/1/2025

USES

Temporarily relieves from fever discomfort, headache, toothache, muscle ache, jointsoreness, drowsiness, fatigue and sunstroke.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 1/1/2025

Other information

Store in a cool place avoiding direct sunlightand high temperature. May even be stored inrefrigerator for extra cooling. Do not store infreezer.

For sanitary purposes, use each sheet onlyonce and discard after use.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/1/2025

Dosage & administration

Apply as needed, do not re-use.

USER SAFETY WARNINGS SECTION

LOINC: 54433-8Updated: 1/1/2025

When using this product

Do not wear this product directly on skin.

Be aware of low-temperature burns.

WARNINGS SECTION

LOINC: 34071-1Updated: 1/1/2025

Warning

For external use only. Avoid direct contact witheyes.lf excessive redness, irritation, burning ordiscomfort of the skin develops, discontinueuse and consult a physician immediately. Donot apply to wounds or to irrtated, damaged,sunburned or very sensitve skin. The coolinggel sheet will not stick to skin if the skin is wetor if the gel sheet comes into contact with haireyebrows or clothing. Keep out of the reach ofchildren.Consult physician if fever persists orcondition worsens.

RECENT MAJOR CHANGES SECTION

LOINC: 43683-2Updated: 3/24/2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

iShanCare - FDA Drug Approval Details